Roundhill GLP-1 & Weight Loss ETF
OZEM
#2852
ETF Rang
€44.6 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
26,87 €
Aktienkurs
0.61%
Veränderung (1 Tag)
34.96%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 13. April 2026Anzahl der Bestände: 29

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
16.15%
Eli Lilly & CoLLY9003
13.17%
Novo Nordisk A/SNVO183834
7.12%
Pfizer IncPFE138419
5.47%
Viking Therapeutics IncVKTX83569
5.23%
Innovent Biologics Inc1801 HK242500
4.96%
Ascletis Pharma Inc1672 HK1133000
3.93%
Roche Holding AGROP SW5146
3.86%
Amgen IncAMGN5762
3.83%
AstraZeneca PLCAZN9819
3.60%
Hanmi Pharm Co Ltd128940 KS5593
3.51%
Zealand Pharma A/SZEAL DC40685
3.42%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.22%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
3.17%
Regeneron Pharmaceuticals IncREGN2218
2.93%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.64%
Structure Therapeutics IncGPCR25378
2.35%
United Laboratories International Holdings Ltd/The3933 HK954000
2.32%
Gubra A/SGUBRA DC22723
2.03%
MBX Biosciences IncMBX34264
1.87%
Gilead Sciences IncGILD7043
1.36%
Rhythm Pharmaceuticals IncRYTM8463
1.32%
Shionogi & Co Ltd4507 JP32700
1.01%
First American Government Obligations Fund 12/01/2031FGXXX526856.59
0.93%
Biohaven LtdBHVN53094
0.45%
WaVe Life Sciences LtdWVE32778
0.41%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.19%
Cash & OtherCash&Other100099.96
0.05%
JAPANESE YENJPY4195210
-0.52%
SWISS FRANCCHF-215321.29